Carbon monoxide (CO) can act as an anti-inflammatory effector in mouse models of
lung injury and disease, through the downregulation of pro-inflammatory
cytokines production, though the underlying mechanisms remain unclear. The
nucleotide-binding oligomerization domain-,
leucine-rich region-, and
pyrin domain-containing-3 (NLRP3)
inflammasome is a
protein complex that regulates the maturation and secretion of pro-inflammatory
cytokines, including interleukin-1β (IL-1β). In this report, we show that the CO-releasing molecule (CORM-2) can stimulate the expression of
pyrin, a negative regulator of the NLRP3
inflammasome.
CORM-2 increased the transcription of
pyrin in the human leukemic cell line (THP-1) in the absence and presence of
lipopolysaccharide (LPS). In THP-1 cells,
CORM-2 treatment dose-dependently reduced the activation of caspase-1 and the secretion of IL-1β, and increased the levels of
IL-10, in response to LPS and
adenosine 5'-triphosphate (
ATP), an NLRP3
inflammasome activation model. Genetic interference of
IL-10 by
small interfering RNA (
siRNA) reduced the effectiveness of
CORM-2 in inhibiting IL-1β production and in inducing
pyrin expression. Genetic interference of
pyrin by
siRNA increased IL-1β production in response to LPS and
ATP, and reversed CORM-2-dependent inhibition of caspase-1 activation. CO inhalation (250 ppm) in vivo increased the expression of
pyrin and
IL-10 in lung and spleen, and decreased the levels of IL-1β induced by LPS. Consistent with the induction of
pyrin and
IL-10, and the downregulation of lung IL-1β production, CO provided protection in a model of
acute lung injury induced by intranasal LPS administration. These results provide a novel mechanism underlying the anti-inflammatory effects of CO, involving the IL-10-dependent upregulation of
pyrin expression.